Cripto antagonism of activin and TGF-beta signaling
    2.
    发明公开
    Cripto antagonism of activin and TGF-beta signaling 审中-公开
    Cripto-Antagonismus von Activin和TGF-β-Signalisierung

    公开(公告)号:EP2135952A2

    公开(公告)日:2009-12-23

    申请号:EP09009758.5

    申请日:2004-09-14

    IPC分类号: C12N15/12 C07K14/71 A61K38/17

    摘要: Cripto, a developmental oncoprotein, antagonizes activin and TGF-β signaling by forming a complex with activin and TGF-β and their type II receptors. This complex precludes the formation of a functional activin/TGF-β•type II•type I complex, thereby blocking the signaling of activin and TGF-β. Cripto may be generally capable of blocking antiproliferative Smad2/3 signals and provides a novel mechanism of oncogenic action with multiple therapeutic implications. Inhibiting the formation of Cripto and activin/TGF-β complex may enhance antiproliferative effects of activin and TGF-β.

    摘要翻译: Cripto是发育中的癌蛋白,通过与激活素和TGF-β2及其II型受体形成复合物拮抗激活素和TGF-β信号传导。 该复合物排除形成功能性激活素/ TGF-βII型复合物,从而阻断激活素和TGF-β的信号传导。 Cripto通常能够阻断抗增殖Smad2 / 3信号并提供具有多种治疗意义的致癌作用的新机制。 抑制Cripto和激活素/ TGF-β复合物的形成可增强激活素和TGF-β2的抗增殖作用。